NXS 6.67% 24.0¢ next science limited

shortfall on rights issue, page-13

  1. 3,589 Posts.
    lightbulb Created with Sketch. 2532
    I think the lack of takeup by directors under what I will call the pure rights element has more to do with greed. I believe as sub-underwriters they would participate in the underwriting fee which from memory was 6%! So in a sense they get an extra discount to us "retail" investors. I am not generally too critical of management but if this is a case of "snouts in the trough" that the rest of us cannot participate in, then it is reprehensible in my opinion.

    regards
    DF
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.